Skip directly to Accessibility Notice

VanEck Biotech ETF

Index Key Points

Underlying Index: MVIS US Listed Biotech 25 Index (MVBBHTR) 

The Index comprises:

U.S. exchange-listed companies that derive most of their revenues from bio-technology, including companies engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment

Companies initially eligible for inclusion in Index:

  • Principally engaged in the bio-technology industry, deriving greater than 50% of revenues from it
  • Full market capitalization exceeding $150 million
  • Three-month average-daily-trading volume of at least $1 million
  • At least 250,000 shares traded per month

Index provider:

MarketVector Indexes

Index Profile

  • Ticker

  • Inception Date

  • Rebalance Frequency


Index Top 10 Constituents (%)  as of 12/31/22

Total Constituents: 25
Constituent Name Ticker Weightings (%)
Amgen Inc AMGN US 12.15
Gilead Sciences Inc GILD US 8.65
Vertex Pharmaceuticals Inc VRTX US 6.84
Moderna Inc MRNA US 5.79
Regeneron Pharmaceuticals REGN US 5.21
Iqvia Holdings Inc IQV US 5.12
Biogen Inc BIIB US 4.83
Illumina Inc ILMN US 4.45
Alnylam Pharmaceuticals Inc ALNY US 4.36
Biontech Se-Adr BNTX US 4.34
Top 10 Total (%) 61.75
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Index Country Weightings (%)
as of 12/31/22

Country % of Net Assets
United States 83.1
Germany 4.3
China 4.2
Ireland 3.9
Netherlands 3.7
Switzerland 0.7

Index Sector Weightings (%)
as of 12/31/22

Sector % of Net Assets
Health Care 100.0

View More Funds